Objective-To examine differences in prescribing between dispensing and non-dispensing practices.
Introduction
All general practitioners prescribe, and most of their patients take their prescriptions to a pharmacy. A minority, however, take their prescriptions to a dispensary within the practice. In 1989-90 the 14% of general practitioners who dispensed drugs' made up 27013820 prescriptions (6.75% of all primary care prescriptions).2
The need for doctors to dispense arose in rural areas to compensate for the absence of pharmacies. Dispensing practices can dispense only for patients who live more than one mile from a pharmacy, so most dispense for only some oftheir patients.
The rural setting of most dispensing practices means that their geographical distribution is uneven. The five family health service authorities with the highest percentage of dispensing practitioners are Lincolnshire (52%),NorthYorkshire (520/%), Cambridgeshire (48%), Norfolk A striking finding is that the cost per patient was similar for both non-dispensing and dispensing patients in dispensing practices. The determinant of cost is thus the dispensing status not of the patient but of the practice, indicating that practice characteristics may be important in explaining the cost differences.
Most practice characteristics, such as rurality and pharmacy location, however, have been shown in this study to be of no importance in explaining these differences. While the number of partners was retained in the final multiple regression model of net ingredient cost per patient, the difference in the average value between dispensing and non-dispensing practices was small, making the contribution to the cost difference only 50/0. The only important contribution from practice characteristics was from the higher numbers of patients over 65, which explained 13% of the difference.
The main determinant of the difference, explaining 84%, was associated with dispensing doctors' reluctance to prescribe generically. Several Another complicating factor is the use of "named generics." Some drugs are available with a brand name at a generic price, and dispensing practices prefer these because they combine the extra security of proprietary prescribing with generic costs. In the returns from the Prescription Pricing Authority these drugs do not appear as part of the generic prescribing percentage, so these data obfuscate the true effect of generic drugs on prescribing costs. A comparative analysis of the use of brand name generics by dispensing and non-dispensing practices is therefore necessary. Even ifbranded generic drugs have some mitigating effect on the generic factor, however, the observed differences must still be explained by other factors.
The three factors in the final multiple regression model predict a total difference in prescribing costs of C6.51 per patient between dispensing and nondispensing practices-which agrees closely with the actual difference of £6.31. The model is therefore effective in highlighting the origins of the differences in average net ingredient cost per patient between the two groups of practices. There is no reason to believe that similar differences are not manifested in other family health services authorities with significant numbers of dispensing practices as the factors will not be specific to Lincolnshire doctors. However, the model is less effective at predicting the individual practice prescribing costs, only 38% of the overall variation being explained. This is somewhat less than can be achieved with aggregated family health services authority data"32 and is most likely associated with individual practice prescribing philosophies and local factors peculiar to the practice, which give individual departures from the model. These practice differences do not appear to be significant when comparing dispensing and non-dispensing practice costs; their average effect must be the same for both groups.
The profitability of a dispensary is closely related to both the overall turnover of stock and the number of precriptions issued, since each prescription attracts a dispensing fee and container allowance. The number of prescriptions can be increased without affecting turnover by decreasing prescribing intervals. While there is no evidence to suggest that financial incentives increase turnover in dispensing practices (as their higher costs per patient are explicable in terms of the regression model), there is, however, evidence to suggest that financial incentives lead dispensing doctors to issue precriptions for shorter periods (tables I and II). The increased number of (cheaper) items prescribed to dispensing patients could be a result of the prescribing of "over the counter" substitutes, but the PACT 3 analysis shows that these patients have 13-7% more items ofthe 10 specific drugs examined, in line with 14% more items overall. Shorter prescribing intervals therefore appear to be the major contributor to the increased number of items prescribed, with precribing of simple remedies thus playing only a minor role. One burden of this increased number of items falls on the patient who pays prescription charges, whose costs will increase.
In summary, dispensing practices in Lincolnshire are relatively high cost prescribers. Their increased numbers of elderly patients explain some of the extra cost, but their prescribing a smaller proportion of generic drugs than other practices is the most significant factor, although their greater use of brand name generics may mitigate this. If brand name generics are important then other factors to explain the differences must be found. The financial incentives connected with shorter prescribing intervals seem to contribute to the higher numbers ofcheaper items being prescribed.
